DE69832216D1 - Rantes Mutanten und deren therapeutischen Anwendungen - Google Patents

Rantes Mutanten und deren therapeutischen Anwendungen

Info

Publication number
DE69832216D1
DE69832216D1 DE69832216T DE69832216T DE69832216D1 DE 69832216 D1 DE69832216 D1 DE 69832216D1 DE 69832216 T DE69832216 T DE 69832216T DE 69832216 T DE69832216 T DE 69832216T DE 69832216 D1 DE69832216 D1 DE 69832216D1
Authority
DE
Germany
Prior art keywords
rantes
therapeutic applications
rantes mutants
mutants
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832216T
Other languages
English (en)
Other versions
DE69832216T2 (de
Inventor
Paolo Lusso
Simona Polo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAN RAFFAELE CENTRO FOND
Original Assignee
SAN RAFFAELE CENTRO FOND
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI972865 external-priority patent/IT1297015B1/it
Priority claimed from IT98MI001866 external-priority patent/IT1302012B1/it
Application filed by SAN RAFFAELE CENTRO FOND filed Critical SAN RAFFAELE CENTRO FOND
Publication of DE69832216D1 publication Critical patent/DE69832216D1/de
Application granted granted Critical
Publication of DE69832216T2 publication Critical patent/DE69832216T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69832216T 1997-12-23 1998-12-21 RANTES-Mutanten und therapeutische Anwendungen davon Expired - Lifetime DE69832216T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI972865 IT1297015B1 (it) 1997-12-23 1997-12-23 Mutanti di rantes e loro applicazioni terapeutiche
ITMI972865 1997-12-23
IT98MI001866 IT1302012B1 (it) 1998-08-07 1998-08-07 Derivati di rantes e loro applicazioni terapeutiche.
ITMI981866 1998-08-07

Publications (2)

Publication Number Publication Date
DE69832216D1 true DE69832216D1 (de) 2005-12-08
DE69832216T2 DE69832216T2 (de) 2006-05-24

Family

ID=26331556

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69832197T Expired - Lifetime DE69832197T2 (de) 1997-12-23 1998-12-21 Rantes-mutanten und therapeutische anwendungen davon
DE69832216T Expired - Lifetime DE69832216T2 (de) 1997-12-23 1998-12-21 RANTES-Mutanten und therapeutische Anwendungen davon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69832197T Expired - Lifetime DE69832197T2 (de) 1997-12-23 1998-12-21 Rantes-mutanten und therapeutische anwendungen davon

Country Status (10)

Country Link
US (2) US6608177B1 (de)
EP (2) EP1040191B1 (de)
JP (1) JP4323094B2 (de)
AT (2) ATE308616T1 (de)
AU (1) AU2415599A (de)
CA (1) CA2316447C (de)
DE (2) DE69832197T2 (de)
DK (2) DK1040191T3 (de)
ES (2) ES2247738T3 (de)
WO (1) WO1999033989A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743594B1 (en) 1995-06-06 2004-06-01 Human Genome Sciences, Inc. Methods of screening using human G-protein chemokine receptor HDGNR10 (CCR5)
US6025154A (en) 1995-06-06 2000-02-15 Human Genome Sciences, Inc. Polynucleotides encoding human G-protein chemokine receptor HDGNR10
UA77950C2 (en) 2000-10-04 2007-02-15 Applied Research Systems Use of mutants of cc chemokines for treatment of multiple sclerosis
WO2003051921A1 (en) 2001-12-17 2003-06-26 Applied Research Systems Ars Holding N.V. Chemokine mutants acting as chemokine antagonists
ATE319471T1 (de) * 2002-04-04 2006-03-15 Applied Research Systems Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit
US7981410B2 (en) * 2006-11-13 2011-07-19 Functional Genetics, Inc. Therapeutic targeting of escort proteins
EP2185719B1 (de) 2007-08-02 2013-11-13 NovImmune SA Rantes-antikörper und verfahren zu ihrer verwendung
CN112469430A (zh) 2018-05-28 2021-03-09 日内瓦大学 抑制大脑炎症的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2207036A1 (en) * 1994-12-08 1996-06-13 Glaxo Group Limited Rantes peptide and fragments and compositions comprising it for treatment of inflammation
FR2748938B1 (fr) * 1996-05-22 1998-07-31 Pasteur Institut Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
WO1998013495A1 (en) * 1996-09-25 1998-04-02 British Biotech Pharmaceuticals Limited Human rantes mutants incapable of aggregate formation

Also Published As

Publication number Publication date
EP1040191A2 (de) 2000-10-04
AU2415599A (en) 1999-07-19
US7164000B2 (en) 2007-01-16
CA2316447C (en) 2009-07-28
EP1040191B1 (de) 2005-11-02
WO1999033989A3 (en) 1999-08-26
ES2247738T3 (es) 2006-03-01
EP1431391A3 (de) 2004-10-06
US20030216549A1 (en) 2003-11-20
DK1040191T3 (da) 2005-12-19
ATE308617T1 (de) 2005-11-15
DE69832197D1 (de) 2005-12-08
JP2002507388A (ja) 2002-03-12
DK1431391T3 (da) 2005-12-19
ATE308616T1 (de) 2005-11-15
JP4323094B2 (ja) 2009-09-02
EP1431391B1 (de) 2005-11-02
ES2247475T3 (es) 2006-03-01
DE69832197T2 (de) 2006-05-24
WO1999033989A2 (en) 1999-07-08
CA2316447A1 (en) 1999-07-08
US6608177B1 (en) 2003-08-19
EP1431391A2 (de) 2004-06-23
DE69832216T2 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
NO911624D0 (no) Farmasoeytiske forbindelser.
DE69739665D1 (de) Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
DE69324826D1 (de) Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
ATE500328T1 (de) Vaskuläre adhesionsmoleküle und modulierung ihrer funktion
ATE218616T1 (de) Humanes zirkulierendes cytokin cc-1
ATE308617T1 (de) Rantes mutanten und deren therapeutischen anwendungen
BR9301641A (pt) Processo para produzir uma preparacao de fator viii,altamente purificada e uso
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
ATE438658T1 (de) Neue polypeptide aus bienengift und dessen gebrauchsverfahren
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
ATE186731T1 (de) Anomere fluorribosylamine
FR2710244B3 (fr) Composition diététique à base d'acides aminés essentiels.
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
Dozeman The Life of Moses: The Yahwist as Historian in Exodus-Numbers
WO2000027881A3 (de) Menschliche interleukin -10 mutantenproteine
Palani Professor Dr. N. Subbu Reddiar's contributions for the enrichment of Tamil
DE3689850D1 (de) Peptide und deren Verwendung in der Therapie.
ITRM920079A1 (it) Manufatto per l'allargamento di banchine stradali e procedimento di posa in opera.
ES2127133A1 (es) Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer.
TH8515EX (th) อุปกรณ์ปรับความดันของก๊าซแบบมีเครื่องตั้งเวลาและตำแหน่งปิด-เปิด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition